BEOVU in the Treatment of Dystrophy-related Macular Neovascular Degeneration
Condition(s):Dystrophy, RetinalLast Updated:December 30, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Dystrophy, RetinalLast Updated:December 30, 2020Unknown status
Condition(s):Retinal Disease; Retinal Degeneration; Retinal DystrophiesLast Updated:July 27, 2021Unknown status
Condition(s):Stargardt Disease; Age-related Macular Degeneration; Other Retinal DystrophiesLast Updated:March 24, 2015Completed
Condition(s):Choroidal Ischemia; Vitelliform Macular Dystrophy; Age-related Macular Degeneration; Central Serous Retinopathy; Retinitis PigmentosaLast Updated:October 23, 2023Active, not recruiting
Condition(s):AMD; Diabetic Retinopathy; Retinal Degeneration; Retinal DystrophiesLast Updated:April 12, 2022Completed
Condition(s):Retinitis Pigmentosa; Dry Age-related Macular DegenerationLast Updated:January 11, 2023Completed
Condition(s):Retinal Disease; Macular Degeneration; Hereditary Retinal Dystrophy; Optic Nerve Disease; GlaucomaLast Updated:October 23, 2019Unknown status
Condition(s):Retinitis Pigmentosa Associated With CNGB1 MutationsLast Updated:March 1, 2024Recruiting
Condition(s):Retinitis PigmentosaLast Updated:July 2, 2017Completed
Condition(s):Infantile Nystagmus SyndromeLast Updated:January 23, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.